Tag: Matthias Leemann

MLL Legal represented Bayer Intellectual Property GmbH in a successful appeal before the Swiss Federal Supreme Court

The patent litigation team of MLL Legal successfully represented Bayer Intellectual Property GmbH in an appeal before the Swiss Federal Supreme Court against decision by the Swiss Federal Patent Court rejecting a request for preliminary injunction against Helvepharm AG’s rivaroxaban generic.

Firm News

MLL Legal | Litigation Team | Victory before the Swiss Supreme Court

After more than a decade of protracted litigation, MLL Legal secured a victory before the Swiss Supreme Court on behalf of an asset management company sued by a former client.